Abstract | The alarmones guanosine tetraphosphate and guanosine pentaphosphate (collectively referred to as (p)ppGpp) are involved in regulating growth and several different stress responses in bacteria. In recent years, substantial progress has been made in our understanding of the molecular mechanisms of (p)ppGpp metabolism and (p)ppGpp-mediated regulation. In this Review, we summarize these recent insights, with a focus on the molecular mechanisms governing the activity of the RelA/SpoT homologue (RSH) proteins, which are key players that regulate the cellular levels of (p)ppGpp. We also discuss the structural basis of transcriptional regulation by (p)ppGpp and the role of (p)ppGpp in GTP metabolism and in the emergence of bacterial persisters.
Bacteria use an array of sensory systems to monitor their environment in order to enable adaptation to stressful conditions. Most of these systems convert external stimuli into changes in the intracellular concentration of a secondary-messenger molecule that functions as a pleiotropic regulator of key molecular targets. There are three common nucleotide-based secondary messengers in bacteria: cyclic AMP, cyclic di-GMP (c-di-GMP), and guanosine pentaphosphate and guanosine tetraphosphate (collectively referred to as (p)ppGpp) 1 . ppGpp and pppGpp are formed by the addition of a pyrophosphate moiety to the 3ʹ position of GDP and GTP, respectively (FIG. 1a) . (p)ppGpp -or magic spot, as it is often referred to -has several important roles in bacterial physiology, in particular through the coordination of cellular responses on exposure to stress
. During exponential growth, (p)ppGpp is present at basal levels and functions as one of the major modulators of bacterial growth rate 2 and a fine-tuner of general metabolism 3, 4 . (p)ppGpp contributes to growth rate control by inhibiting the production of ribosomal RNA 5 . This occurs, for example, when nutrient limitation causes the growth rate to decline, and cellular resources and energy are directed away from ribosome biosynthesis to be used instead for the upkeep of general metabolism 6 . Regulation of general metabolism by (p)ppGpp is exerted by its action on multiple processes: first, at the level of transcription, (p)ppGpp controls the expression of genes involved in amino acid biosynthesis 5 ; second, it regulates nucleotide metabolism by binding directly to the enzymes involved in nucleotide biosynthesis 7 and uptake 8 .
On exposure to stresses such as nutrient deprivation or heat shock, the cellular concentration of (p)ppGpp increases, and the alarmone orchestrates concentrationdependent reprogramming of many processes, including transcription 9 . These physiological changes are commonly referred to as the stringent response. Several classes of enzymes regulate the intracellular concentration of (p)ppGpp (FIG. 1b) . The RelA-SpoT homologue (RSH) family of bifunctional proteins are the key players, synthesizing (p)ppGpp from ATP and either GTP or GDP, and degrading (p)ppGpp to pyrophosphate and either GTP or GDP 5, 10 . Degradation of (p)ppGpp is also carried out by non-RSH enzymes called Nudix hydrolases 11, 12 , which are widely distributed enzymes capable of hydrolysing a range of nucleoside 5ʹ-diphosphate (NDP) compounds 13 . Rapid conversion of pppGpp to ppGpp is specifically catalysed by pppGpp phosphohydrolase (GppA; also known as pppGpp pyrophosphatase) 14 , and other GTPases can also function in this capacity, such as the translational GTPase elongation factor G (EF-G) 15 , which catalyses translocation of the ribosome during protein synthesis.
The stringent response and (p)ppGpp have important roles in the regulation of bacterial virulence 16 , survival during host invasion 17 , antibiotic resistance 18 and persistence 19 . In this Review, we focus on recent progress in the understanding of the 'nuts and bolts' of the bacterial stringent response machinery: the structure and function of the RSH proteins, the molecular mechanism of RNA polymerase (RNAP) regulation by (p)ppGpp, the recently identified role of (p)ppGpp in GTP biosynthesis,
GTPases
Enzymes that bind and hydrolyse GTP to produce GDP.
Recent functional insights into the role of (p)ppGpp in bacterial physiology Translocation A step in the elongation cycle of the ribosome in which the mRNA-tRNA complex advances on the ribosome by a distance of one codon. b | (p)ppGpp metabolism in Escherichia coli is depicted. The long RSHs RelA and SpoT synthesize pppGpp from GTP and ppGpp from GDP, generating AMP as a by-product. Interconversion of pppGpp to ppGpp (dashed arrows) is catalysed by pppGpp phosphatase (GppA) and translational GTPases, such as the translocase elongation factor G (EF-G) 15 . SpoT catalyses the degradation of pppGpp and ppGpp to form GTP and GDP, respectively 39 . Interconversion of GDP to GTP (dashed arrow) is catalysed by nucleoside diphosphate kinase (Ndk) 76 . c | The domains of the long RSHs SpoT, RelA and Rel are shown, along with the distribution of these proteins in bacteria. The coloured boxes representing each domain show their approximate location along the length of the proteins, with dashed borders indicating domains with reduced or absent functional activity. In the case of the SpoT (p)ppGpp synthesis (SYNTH) domain, synthetic activity is weak, whereas hydrolytic activity is completely absent in the RelA (p)ppGpp hydrolysis (HD) domain. The HD and SYNTH domains comprise the amino-terminal domain (NTD), whereas the TGS (ThrRS, GTPase and SpoT), helical, conserved cysteine (CC) and ACT (aspartokinase, chorismate mutase and TyrA) domains together comprise the carboxy-terminal domain (CTD). The phylogenetic tree summarizes the evolutionary relationships among bacteria that contain or lack long RSHs. The arrow indicates the duplication event that led to the emergence of RelA and SpoT from an ancestral Rel protein in the lineage of the Gammaproteobacteria and Betaproteobacteria. Species from the Planctomycetes, Verrucomicrobia and Chlamydiae (PVC) superphylum of bacteria do not encode any long RSHs. In the absence of a reliable root of the bacterial tree of life, it is not known whether long RSHs evolved after the divergence of PVC bacteria, or whether the enzymes were lost in this lineage. P i , inorganic phosphate; PP i , pyrophosphate. 
A-site
The ribosome acceptor site, which accommodates tRNA and various protein factors during the translation cycle.
Deacylated tRNAs
tRNAs that are uncharged, as they lack an aminoacyl group at the 3ʹ-CCA end.
and the long-speculated connection between the stringent response and bacterial persistence.
RSHs and (p)ppGpp homeostasis
The enzymes that synthesize and degrade (p)ppGpp are highly conserved in bacteria 10 . Genes that encode RSHs are absent only in bacteria from the phyla Planctomycetes, Verrucomicrobia and Chlamydiae (the PVC super phylum), as well as in a few other speciesmainly obligate intracellular endosymbionts such as Buchnera aphidicola and 'Candidatus Carsonella ruddii', and pathogens with reduced genomes, such as Treponema pallidum, some species in the genus Mycoplasma and some species in the order Rickettsiales 10 . There are two types of RSH enzymes: 'short' enzymes, which consist of a single domain
, and 'long' enzymes, which contain multiple domains 10 . Historically, the study of the stringent response initially focused on the gammaproteobacterium Escherichia coli, the workhorse of bacterial genetics. In this organism, the stringent response is orchestrated by two multidomain RSH enzymes -RelA 20 and SpoT 21 -that originated through a gene duplication event in the evolutionary lineage to the classes Betaproteobacteria and Gammaproteobacteria, and are encoded by most species in these classes. These two proteins share the same six-domain structure, comprising a (p)ppGpp hydrolysis domain (HD); a (p)ppGpp synthesis (SYNTH) domain; a ThrRS, GTPase and SpoT domain (TGS domain; ThrRS (Thr-tRNA synthetase; also known as ThrS)); a helical domain; a domain containing conserved cysteines (CC); and an aspartokinase, chorismate mutase and TyrA domain (ACT domain; TyrA (T protein)) 10 (FIG. 1c) . The exact molecular functions of the TGS, helical, CC and ACT domains -collectively referred to as the carboxyterminal domain (CTD) -are unclear, but it has been suggested that these domains regulate the enzymatic activities of the amino-terminal domain (NTD), which contains the HD and SYNTH domains 22 .
RelA. The activities of RelA and SpoT are regulated by different stress signals. The bifunctional RSH SpoT senses a limitation of several nutrients -carbon sources, phosphate, iron and fatty acids -and both synthesizes and hydrolyses (p)ppGpp [23] [24] [25] (FIG. 1b) . RelA is capable of (p)ppGpp synthesis only (FIG. 1b) , and this activity is induced by amino acid starvation 26 and heat shock 27 . These functional differences between RelA and SpoT are reflected in the domain conservation of the proteins (FIG. 1c) : although RelA retains a relic of the HD domain, it is highly divergent from that of SpoT and lacks hydrolytic activity 10, 28 .
RelA is a ribosome-associated protein that senses amino acid starvation by directly monitoring the translational capacity of the cell. During normal growth (defined here as exponential growth in the absence of amino acid limitation), amino acids are delivered to the ribosomal acceptor site (A-site) in the form of aminoacylated tRNA molecules, and are added to the nascent polypeptide as it is synthesized. During amino acid starvation, deacylated tRNAs accumulate and enter the A-site, thereby strongly activating the (p)ppGpp synthesis activity of RelA 29 (FIG. 2a) . The 3ʹ-OH group of the terminal adenosine of the tRNA molecule is crucial for the activation of RelA, which suggests that the aminoacylation state of tRNAs is directly inspected by RelA 30 . It has been shown that in the absence of nucleotide substrates (ATP, and GDP or GTP) for the synthesis of (p)ppGpp, the presence of a deacylated tRNA in the A-site promotes the binding of enzymatically idle RelA to the ribosome. However, stabilization of the deacylated tRNA-ribosome interaction in the presence of enzymatically idle RelA has not been detected 31, 32 . This is surprising because regardless of the order of association events (whether the tRNA or RelA binds first), the same ternary complex is formed (RelA-deacylated tRNA-70S ribosome), and one would therefore expect mutual stabilization of RelA and tRNA binding to the ribosome. On synthesis of (p)ppGpp, RelA was initially proposed to dislodge the tRNA from the ribosome 33 , but this was not supported by a subsequent study 32 in which a 'hopping' model was proposed. This model suggests that the process of (p)ppGpp synthesis by ribosome-bound RelA dislodges RelA from the complex, and that by 'hopping' between ribosomes, RelA can monitor the translational status of the cell 32 . Recent single-molecule in vivo analysis
Box 1 | Molecular targets of (p)ppGpp
Guanosine tetraphosphate and guanosine pentaphosphate (collectively referred to as (p)ppGpp or the alarmone) exert their regulatory effects using both direct and indirect mechanisms (see the figure) . The indirect mechanisms include an alteration in the nucleoside 5ʹ-triphosphate pool as a result of GTP depletion during the stringent response. This strategy is the main pathway of RNA polymerase (RNAP) regulation in Bacillus subtilis: the depletion of GTP alters the balance of available initiating nucleotides, which results in changes in the promoter preferences of RNAP 63 . Another important target of indirect regulation is the transcriptional repressor CodY, which inhibits the expression of more than 100 target genes involved in adaptation to stress and sporulation 84 . CodY is activated by the binding of GTP and branched amino acids in B. subtilis 84 , and depletion of GTP during the stringent response causes de-repression of the CodY-regulated gene network. The direct effects of (p)ppGpp are exerted through binding to target enzymes. This includes regulation of transcription in Escherichia coli via the effects of the alarmone on RNAP 66, 67 , in addition to inhibition of protein biosynthesis by inhibiting translational GTPases (such as translation initiation factor 2 (IF2)) 111, 112 , inhibition of DNA replication by the targeting of DNA primase (DnaG) 113 , inhibition of polyphosphate metabolism through polyphosphate kinase (PPK) targeting (which also leads to persistence) 102 , and inhibition of the acid stress response via the targeting of inducible lysine decarboxylase (LdcI; also known as CadA) 114 . Direct binding of the alarmone to RelA also positively regulates (p)ppGpp synthesis 28 . Recent sequence analysis and docking studies have further expanded this list of (p)ppGpp-binding enzymes to include new potential targets, such as orotate phosphoribo syltransferase (OPRTase) and glutamine phosphoribosylpyrophosphate amidotransferase (GPATase; also known as ATase), but these await experimental validation 114 . For an overview of (p)ppGpp-mediated regulation of molecular targets and the implications of this regulation for bacterial virulence, we refer the reader to an excellent review 109 .
Sarcin-ricin loop (SRL). An essential structural element of the 23S ribosomal RNA; this loop interacts with various protein factors during translation.
A/T state
A structural conformation of an aminoacyl-tRNA, in which the charged tRNA becomes distorted as it occupies the ribosomal A-site while interacting with elongation factor Tu. suggests a modified model 34 : activation of RelA during amino acid starvation was shown to induce RelA dissociation from the ribosome; however, multiple rounds of (p)ppGpp synthesis occurred off the ribosome, rather than on the ribosome. This model implies that there is a 'molecular memory' , such that RelA remains in an active state after dissociation from the ribosome. In addition to deacylated tRNA, the other allosteric activator of RelA is its product ppGpp 28 , resulting in a conditional positive feedback loop. The presence of ppGpp alone is insufficient to induce the maximum catalytic activity of RelA, but it potentiates the activation that is induced by the ribosome and by deacylated tRNA in the A-site.
Our understanding of the structural aspects of RelA enzymatic activity is based on a recent low-resolution cryoelectron microscopy (cryo-EM) structure 35 . On binding to the A-site, RelA interacts with the sarcinricin loop (SRL) and 50S L11 (FIG. 2b) . In support of the cryo-EM structure, ribosomal protein L11 has been shown to be crucial for the activation of RelA 36 . RelA interacts directly with the A-site tRNA, which adopts an unusual conformational state that resembles the A/T state of the aminoacyl tRNA in complex with elongation factor Tu (EF-Tu) on the ribosome 37 (FIG. 2c) . Despite it lacking in molecular detail, the current structure provides a framework for understanding the well-documented inhibition of RelA by the antibiotic thiostrepton 26 , which intercalates between L11 and helices 43 and 44 of the 23S rRNA 38 , and provides an explanation for the observation that active protein synthesis and RelA activation on the ribosome are mutually exclusive events.
SpoT. RelA seems to respond specifically to amino acid starvation, whereas SpoT is a hub protein that integrates various stress signals, including fatty acid 23 , iron 24 and carbon source 25 starvation. Unlike RelA, E. coli SpoT has both weak synthetic activity and strong hydrolytic activity for (p)ppGpp 25, 39 (FIG. 1c) . Interestingly, patterns of SpoT sequence conservation in the Moraxellaceae family of gammaproteobacteria suggest that the synthetic activity of the enzyme is gradually being lost, indicating that there is an ongoing partitioning of functions for RelA and SpoT in this lineage 10 ; however, this proposal requires further experimental validation. The hydrolysis function of SpoT is crucial for balancing cellular (p)ppGpp concentrations in the presence of RelA, and disruption of the spoT gene in E. coli is therefore lethal 25 . Several molecular partners of SpoT have been identified: it has been suggested that direct interactions with the GTPase Obg (also known as ObgE and CgtA) repress the (p)ppGpp-synthetic activity of SpoT under nutrientrich conditions 40 , whereas acyl carrier protein (ACP) activates SpoT during fatty acid starvation 41 . Simultaneous disruption of spoT and the β-ketoacyl-ACP synthase III gene (fabH) in E. coli leads to synthetic lethality 42 , underscoring the intimate connection between SpoT and fatty acid metabolism. However, the molecular details of these regulatory mechanisms are unknown, as all attempts to purify full-length recombinant SpoT from E. coli have so far been unsuccessful. This has limited biochemical investigations to the characterization of the crude, partially purified protein 39, 43, 44 , and structural information is lacking altogether.
Rel. In the majority of bacteria (that is, species outside the classes Gammaproteobacteria and Betaproteobacteria), (p)ppGpp concentration is regulated by a single RSH protein, Rel, which has both synthetic and hydrolytic activities, like SpoT (FIG. 1c) . Biochemical investigations of Rel have focused mostly on the Mycobacterium tuberculosis enzyme, owing to its importance for the long-term survival of non-replicating persister bacteria during chronic infection 45, 46 . In a reconstituted in vitro system, the synthetic activity of M. tuberculosis Rel
Box 2 | Diversity and nomenclature of RSHs
The long, multidomain RelA-SpoT homologues (RSHs) have been known for decades and have been used as prototypes for studying the stringent response. Recently, short, single-domain, monofunctional RSHs -small alarmone synthetases (SASs) and small alarmone hydrolases (SAHs) -have been discovered in various bacterial species, such as Mycobacterium smegmatis 115 , Bacillus subtilis 116 and Streptococcus mutans 117 . Phylogenetic analysis has identified 20 subgroups of these enzymes, which are typically present only in organisms that encode a long RSH 10 . With the exception of the M. smegmatis SAS (MS_RHII-RSD, which has additional RNase activity 115 ), SASs and SAHs are single-domain enzymes. Although biochemical data suggest that these proteins do not require additional interaction partners for the regulation of their enzymatic activities, it is impossible to rule out the existence of unidentified partners, similar to those involved in the regulation of long RSHs 116 . The activity of SAS enzymes seems to be primarily regulated at the transcriptional level: expression of the B. subtilis SAS RelQ (also known as YwaC) is upregulated as part of the σ W regulon in response to cell wall damage 118 , and transcription of a second B. subtilis SAS, RelP (also known as YjbM), is upregulated by alkaline shock 116 . Several X-ray structures of putative SASs have been solved and deposited in the Protein Data Bank (PDB; for example, an S. mutans protein (PDB 3L9D) and a Streptococcus pneumoniae protein (PDB 2BE3)), but the functionality of these enzymes has not been tested, and the structures are not yet published.
An SAH, metazoan SpoT homologue 1 (MESH1), that is structurally similar to bacterial SAHs has been identified in humans and other animals 10, 119 . MESH1 is capable of hydrolysing ppGpp in vitro 119 , but the physiological role of this protein is unclear, given the absence of (p)ppGpp-synthesizing RSH enzymes 10 and detectable (p)ppGpp in these organisms 119, 120 . Although several chloroplast-encoded RSHs are widely distributed in plants 121 , the only other eukaryotes that have so far been found to encode cytoplasmic (p)ppGpp synthetase homologues are the amoebae Dictyostelium discoideum and Dictyostelium purpureum, the fungi Aspergillus nidulans, Aspergillus fumigatus and Gibberella zeae, and the heterokont algae Thalassiosira pseudonana and Phaeodactylum tricornutum 10 . The potential functional roles of (p)ppGpp in these organisms are unknown; however, D. discoideum uses another secondary messenger, cyclic AMP, as a secreted signalling molecule for cellular aggregation 122 , which raises the question of whether (p)ppGpp has a similar role in extracellular communication.
The use of standardized nomenclature is particularly important, as RSH proteins from different organisms are often named in an idiosyncratic manner. An extensive bioinformatic analysis of RSH enzymes has provided a foundation for the rational terminology of RSHs 10 . This phylogenetic analysis identified 30 distinct RSH subgroups that comprise 11 long, multidomain RSHs (Rel, SpoT, RelA, RshA, RshB, RshC, RshD, Rsh1, Rsh2, Rsh3 and Rsh4), 7 SAHs (paSpo, pbcSpo, pbcSpo2, Mesh1, Mesh1L, rickSpo and divSpo) that have the (p)ppGpp hydrolase (HD) domain only, and 12 SASs (actRel, bdRel, cloRel, fpRel, fpRel2, gRel, capRel, rickRel, RelP, RelQ, RelV and divRel) that have the (p)ppGpp synthesis (SYNTH) domain only. Not all of these groups are monophyletic; Rel is paraphyletic to the other long RSHs, as RelA, SpoT and other long RSHs evolved from the more ancient Rel subfamily. divRel and divSpo do not define co-clustering clades but refer to miscellaneous and divergent sequences that contain only the SYNTH or HD domain, respectively.
Elongation factor Tu
(EF-Tu). A GTPase that delivers aminoacyl-tRNAs to the ribosomal A-site during protein synthesis.
Acyl carrier protein
(ACP). An essential component of the fatty acid synthesis pathway that stabilizes and transports the growing lipid chain. Specialized ACPs are also involved in other processes that require acyl transfer, such as the synthesis of polyketide antibiotics.
An operon that is regulated by the transcription factor σ W and that is induced in response to various stresses.
Monophyletic
Pertaining to a clade in a phylogenetic tree: sharing a single common ancestor.
Paraphyletic
Pertaining to a clade in a phylogenetic tree: sharing a single common ancestor but excluding some descendent sequences.
was strongly stimulated by ribosomes that contained a deacylated tRNA in the A-site, whereas no effect on the hydrolytic activity 47 was observed, suggesting that Rel is the functional counterpart of RelA in terms of its role in acute (p)ppGpp synthesis in response to amino acid starvation. However, experiments with live M. tuberculosis showed that amino acid starvation induced by serine hydroxamate (SHX; a competitive inhibitor of Ser-tRNA synthetase that leads to the accumulation of deacylated tRNA Ser in E. coli and Bacillus subtilis) did not lead to (p)ppGpp accumulation, and complete starvation (absence of all nutrients, induced by transferring the bacteria to a saline buffer) was required for induction of the stringent response 46 . Similarly, the stringent response was not induced in Helicobacter pylori following exposure to SHX 48 , but it was induced after a nutritional downshift 49 and carbon dioxide deprivation 50 . However, as amino acid analogues such as SHX have been shown to be ineffective at eliciting the stringent response in some bacterial species, including H. pylori 49 , the sensitivity of tRNA synthetases to this analogue and the efficiency of analogue uptake into bacterial cells should be considered in such experiments. Regardless of these potential experimental caveats, it is clear that the precise triggers of the stringent response seem to vary between species. For example, Caulobacter crescentus requires additional stimuli such as carbon or nitrogen starvation -not only amino acid starvation alone -to elicit the Rel-mediated stringent response 51 . This contrasts with reports of amino acid starvation being sufficient to induce (p)ppGpp synthesis by Rel in other organisms, such as Enterococcus faecalis 52 53 and Streptomyces coelicolor A3(2) 54 . It has been proposed that such differences in the triggers of the stringent response reflect adaptations to the distinct lifestyles of each species 55 . Unlike SpoT, Rel does not seem to be regulated by ACP 56 , and whether Obg-mediated regulation occurs is unknown; so far, this has been tested only for SpoT and RelA in E. coli 57, 58 and Vibrio cholerae 40 . An X-ray crystal structure of a truncated Rel from Streptococcus dysgalactiae subsp. equisimilis is available, but unfortunately the regulatory domains of the enzyme are unresolved, which limits structural interpretation of the available biochemical data 59 . . This ribosomal state is recognized by RelA, which binds to the 50S ribosomal subunit and adopts an active conformation in the presence of a deacylated tRNA in the A-site. Activation of RelA and consequent synthesis of guanosine tetraphosphate and guanosine pentaphosphate (collectively referred to as (p)ppGpp) leads to the dissociation of RelA from the ribosome, followed by several rounds of (p)ppGpp synthesis by RelA in the dissociated state 32, 34 . Increased (p)ppGpp levels direct cellular metabolic resources to amino acid biosynthesis, which restores normal levels of tRNA aminoacylation. Aminoacylated (charged) tRNA is delivered to the ribosome by elongation factor Tu (EF-Tu) and inhibits the binding of RelA and deacylated tRNA. b,c | The cryoelectron microscopy (cryo-EM) structure of RelA in complex with the ribosome is shown. On binding to the ribosomal A-site, RelA interacts with the sarcin-ricin loop (SRL) and 50S ribosomal protein L11 (part b), as well as with the deacylated tRNA in the A-site, which adopts a highly distorted conformation (referred to as the A/T state) (part c). The RelA cryo-EM structure (EMDataBank accession EMD-2373) is reproduced, with permission, from REF. 35 , Wiley.
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Myxococcus xanthus
Regulation of transcription by (p)ppGpp Accumulation of (p)ppGpp during stress conditions results in alterations in gene expression owing to changes in RNAP activity. For example, during periods of amino acid starvation, (p)ppGpp inhibits transcription from the promoters of rRNA and ribosomal protein genes, but it activates transcription from the promoters of amino acid biosynthesis genes 5, 60 . In the case of E. coli RNAP, (p)ppGpp interacts directly with RNAP to destabilize the short-lived open complexes that form at certain promoters, such as the promoters of rRNA genes, thereby directly inhibiting transcription initiation 61, 62 . In other bacteria, including B. subtilis, (p)ppGpp downregulates transcription without directly interacting with RNAP. This indirect inhibition occurs because production of the alarmone leads to the consumption of GTP and because the alarmone itself inhibits the enzymes responsible for GTP synthesis 3 ; together, these effects reduce the cellular pool of GTP, resulting in a decline in the GTP/ATP ratio. This in turn modulates the expression of genes that are governed by promoters sensitive to the concentration of the initiating nucleotide, such that transcription is downregulated for genes beginning with a guanosine but activated for genes beginning with adenosine 3, 63 . A crystal structure of Thermus thermophilus RNAP in complex with ppGpp showed that the nucleotide binds near the active site of RNAP 64 . However, subsequent studies with E. coli RNAP found that amino acid substitutions in the vicinity of the putative ppGpp-binding site (as determined from the T. thermophilus RNAP structure) had no effect on ppGpp-dependent regulation of these E. coli RNAP mutants; moreover, this work demonstrated that ppGpp did not substantially affect transcription initiation by the T. thermophilus RNAP 65 . Therefore, this study suggests that (p)ppGpp has an indirect effect on the activity of the T. thermophilus RNAP, and it also questions the relevance of the structural data from the T. thermophilus RNAP for predicting the role of ppGpp in the regulation of transcription in E. coli. In 2013, two studies reported the crystal structure of the E. coli RNAP in complex with ppGpp 66, 67 . These structures revealed that the ppGpp-binding site is located in a cavity surrounded by the α-, βʹ-and ω-subunits of RNAP, and that the nucleotide interacts with the surface of a double-psi β-barrel (DPBB) domain in the βʹ-subunit and with the N terminus of the ω-subunit (FIG. 3a) , which is ~30 Å away from the active site of RNAP. pppGpp binds to the same site on RNAP as ppGpp but with lower potency 66 . This newly located (p)ppGpp-binding site is consistent with previous observations that the presence of the ω-subunit is required for ppGpp-dependent transcription inhibition in vitro 68, 69 . Amino acid substitutions in the (p)ppGpp-binding region of the ω-and βʹ-subunits make RNAP unresponsive to (p)ppGpp, indicating that this binding site is indeed required for modulating the activity of E. coli RNAP during the stringent response 70 .
Models for (p)ppGpp-mediated regulation of transcription.
Residues at the (p)ppGpp-binding site are not directly involved in RNAP enzymatic activity or in binding of the DNA template, which suggests an allosteric mechanism for (p)ppGpp-dependent modulation of RNAP activity. As mentioned above, the (p)ppGppbinding site is located on the surface of a DPBB domain of the βʹ-subunit (FIG. 3a) . The other side of the DPBB domain faces the cleft containing the RNAP active site and coordinates the catalytic Mg 2+ , which is central to RNAP activity. There are two proposed working models to explain how (p)ppGpp binding regulates RNAP.
According to the first model, binding of (p)ppGpp to the surface of the DPBB domain induces an allosteric signal that is transmitted to the other side of the DPBB domain, which coordinates the catalytic Mg 2+ for the nucleotidyl transfer reaction; in this way, the alarmone regulates the catalytic efficiency of RNAP 66 . In the second model, (p)ppGpp binding is suggested to influence the shelf and core domains of RNAP 71 , as the alarmone binds at the interface of these two mobile modules. The coordinated motion of these modules, which is known as shelf-core ratcheting, causes global and local conformational changes in RNAP, including the swinging of the DNA-binding clamp 72 (FIG. 3a) . Thus, the binding of (p)ppGpp at the junction of these mobile RNAP modules is proposed to determine the opening and closing of the DNA-binding clamp, and to thereby influence the stability of RNAP-promoter complexes 67, 70 . However, neither of these models has so far been tested experimentally, so the molecular mechanism of (p)ppGpp regulation remains elusive.
The amino acid residues of the βʹ-and ω-subunits are involved in guanine nucleobase recognition and interactions with the phosphate backbone, respectively. The N-terminal methionine residue of the ω-subunit is cleaved by methionine aminopeptidase, an event that is required for accommodation of the (p)ppGpp phosphate backbone 66 . Methionine aminopeptidase preferentially cleaves the N-terminal methionine when the second amino acid residue is one with a short side chain, such as alanine, as is the case for the E. coli ω-subunit. The third amino acid residue, arginine, is important for mediating interactions with the phosphate group of (p)ppGpp. Thus, the ω-subunit N-terminal sequence MAR represents a signature for the ability of RNAP to interact with (p)ppGpp.
An alignment of the N-terminal sequence of bacterial ω-subunits 70 (FIG. 3b) shows that the MAR motif is found in species from the class Gammaproteobacteria and the closely related classes Alphaproteobacteria, Beta proteobacteria and Deltaproteobacteria, suggesting that the RNAPs encoded by these bacterial lineages accommodate (p)ppGpp at the ω-subunit and probably use direct inhibition by (p)ppGpp for the modulation of transcription. By contrast, the ω-subunits from bacteria in other classes do not contain the MAR motif, which indicates that they do not use this (p)ppGpp-binding site. These other species may use the indirect mechanism of RNAP regulation that has been observed in B. subtilis or may have an as yet unidentified (p)ppGpp-binding site, as is the case for the RNAPs of M. tuberculosis 73 ) in complex with promoter DNA is depicted. This structure shows how guanosine tetraphosphate and guanosine pentaphosphate (collectively referred to as (p)ppGpp) and DksA interact with RNAP. The model shows (p)ppGpp (dark blue) in its binding site on RNAP, which is located in the double-psi β-barrel (DPBB) domain (dark pink) of the βʹ-subunit and the amino terminus of the ω-subunit. Binding of (p)ppGpp to this site is suggested to induce an allosteric signal to the catalytic Mg 2+ (red sphere), which is thought to regulate the catalytic efficiency of RNAP. Alternatively, (p)ppGpp binding at the junction of the mobile shelf and core domains may result in ratcheting, which could cause swinging of the DNA-binding clamp, thereby modulating RNAP activity. The black dashed line indicates the shelf-core ratcheting axis, and black arrows show the proposed direction of ratcheting and swinging of the DNA-binding clamp. DksA binds to the E. coli RNAP secondary channel (shown by a dashed arrow), which may influence the orientation of the core and shelf modules and thereby enhance the activity of (p)ppGpp. This model was constructed by combining the X-ray crystal structures of the E. coli RNAP-ppGpp complex (Protein Data Bank (PDB) accessions 4JK1 and 4JKR), the Thermus thermophilus RNAP-promoter DNA complex (PDB accession 4G7H) and E. coli DksA (PDB accession 1TJL). b | Taxonomic distribution of the MAR motif is shown. Alignment of the N-terminal region of the ω-subunit shows that the MAR motif which (p)ppGpp binds to is conserved only in bacteria from the classes Alphaproteobacteria, Betaproteobacteria, Deltaproteobacteria and Gammaproteobacteria. This suggests that the ancestor of proteobacteria carried the MAR motif, and it was subsequently lost in the lineage that gave rise to the class Epsilonproteobacteria. The phylogenetic tree on the left shows the evolutionary relationships among the groups of bacteria and was constructed according to REF. 127 .
Salvage pathway
A pathway in which nucleotides are synthesized from intermediates (nucleobases and ribonucleosides that are either the products of degradative processes within the cell or imported from the extracellular milieu), rather than de novo, from phosphoribosyl pyrophosphate as a starting compound.
the ω-subunit can be used to predict direct (p)ppGppdependent transcriptional regulation, but biochemical experiments are needed to clarify the mechanisms involved.
The role of DksA. In addition to (p)ppGpp, the transcription factor DksA has a crucial role in the stringent response, as it amplifies the effect of (p)ppGpp-dependent transcriptional regulation. DksA binds close to the RNAP secondary channel (which is proposed to transport nucleotide substrates to the active site) and inserts its coiled-coil domain into this channel to reach the active site 75 (FIG. 3a) . As (p)ppGpp and DksA bind RNAP on opposite surfaces, there is no physical interaction between them. DksA binds the RNAP secondary channel in a manner similar to that of the T. thermophilus transcription inhibitor Gfh1, which widens this channel, thereby influencing the orientation of the core and shelf modules 71 . The RNAP-DksA interaction probably makes RNAP more sensitive to the shelf-core ratcheting that is induced by (p)ppGpp, thereby amplifying the signal from (p)ppGpp during transcriptional regulation.
Regulation of GTP biosynthesis by (p)ppGpp
In most bacteria, there are two pathways responsible for GTP biosynthesis: the de novo pathway and the salvage pathway. Both pathways converge on the production of inosine 5ʹ-phosphate (IMP), a key intermediate in the synthesis of the purine nucleoside triphosphates ATP and GTP 76 (FIG. 4) . The de novo pathway uses phosphoribosyl pyrophosphate (PRPP) as a starting compound for the multistep pathway of IMP synthesis. IMP is first converted into xanthosine 5ʹ-phosphate (XMP) by IMP dehydrogenase (GuaB), and GMP synthase (GuaA) then converts XMP into GMP. GMP is transformed into the final product, GTP, via sequential rounds of phosphorylation: the GMP kinase (Gmk) catalyses the conversion of GMP into GDP, which is then converted to GTP by NDP kinase (Ndk). By contrast, the salvage pathway uses purines as the starting compounds for GTP synthesis. The nucleobase guanine and the corresponding ribonucleoside, guanosine, are converted directly to GMP, whereas the nucleobase hypoxanthine and the corresponding ribonucleoside, inosine, serve as substrates for the formation of IMP. Guanine and hypoxanthine are very similar chemically: the two compounds differ only in the presence or absence, respectively, of an amino group on the base C2 atom. As a result, they are recognized by the same proteins: both are substrates of hypoxanthine phosphoribosyltransferase (HprT), which converts these compounds to GMP and IMP, respectively 76 . Guanine and hypoxanthine are imported from the environment via the same transporters 77 , and both function as direct repressors of the gua operon, which encodes the enzymes (GuaA and GuaB) that catalyse the conversion of IMP to GMP 78 . Moreover, the nucleoside forms, guanosine and inosine, are converted to GMP and IMP, respectively, by the same enzyme: inosine-guanosine kinase (Gsk) 76 . The importance of (p)ppGpp for nucleotide metabolism was first recognized in E. coli more than four decades ago 79 , and the GTP biosynthesis pathway was subsequently shown to be directly regulated by (p)ppGpp 7 . The IMP dehydrogenase, GuaB, was initially identified as the main target of (p)ppGpp in E. coli 7, 80 ; however, recent work has shown that the molecular targets of (p)ppGpp-mediated regulation vary according to the species examined. In B. subtilis, GuaB is only weakly Nature Reviews | Microbiology In Escherichia coli, the salvage pathway (red) utilizes either guanosine (GUO), guanine (GUA), inosine (INO) or hypoxanthine (HPX) as substrates. Guanosine kinase (Gsk) converts the nucleosides guanosine and inosine to GMP and inosine 5ʹ-phosphate (IMP), respectively. The de novo pathway uses phosphoribosyl pyrophosphate (PRPP) as a starting compound for the multistep synthesis of IMP, which is further converted to GTP. The transformation is achieved in four steps: IMP is first converted into xanthosine 5ʹ-phosphate (XMP) by IMP dehydrogenase (GuaB), and GMP synthase (GuaA) then converts XMP into GMP. GMP is transformed into the final product, GTP, via sequential rounds of phosphorylation: GMP kinase (Gmk) catalyses the conversion of GMP into GDP, which is then converted to GTP by nucleoside diphosphate kinase (Ndk). Cellular GTP concentrations have a dual effect on bacterial physiology. When a threshold concentration is reached, GTP increases bacterial growth rate. However, further increases lead to cytotoxic effects, and at high concentrations GTP inhibits growth and counteracts bacterial survival during amino acid starvation. The specific targets of guanosine tetraphosphate and guanosine pentaphosphate (collectively termed (p)ppGpp)-mediated control vary according to species and differ in E. coli 7, 81 , Bacillus subtilis 3 and Enterococcus faecalis 4 . In E. coli, (p)ppGpp inhibits GuaB; in B. subtilis and E. faecalis, (p)ppGpp inhibits hypoxanthine phosphoribosyltransferase (HprT; the enzyme that catalyses conversion of both hypoxanthine to IMP and guanine to GMP); in B. subtilis, (p)ppGpp also inhibits Gmk. Toxin-antitoxin module (TA module). A bacterial system that involves a toxin and an antitoxin that neutralizes its cognate toxin (for type II TA systems). The toxins of these systems collectively inhibit several essential cellular functions, such as translation, DNA replication and cell wall synthesis.
Lon protease
An ATP-dependent protease that degrades aberrant and short-lived polypeptides.
inhibited by (p)ppGpp 3 , whereas HprT and Gmk are strongly inhibited 3 . In E. faecalis, (p)ppGpp targets HprT but not Gmk 4 ; similarly, Gmk is insensitive to (p)ppGpp in E. coli and Synechococcus elongatus PCC 7942 (REF. 81 ). These differences in the primary targets of (p)ppGpp are expected to translate into variations in the regulation of GTP biosynthesis in different bacterial species. Regulation is also likely to be further complicated by the effects of (p)ppGpp on nucleotide uptake 8, 82 and by the mode of inhibition (competitive or non-competitive), so further investigations are necessary to establish the precise effects of (p)ppGpp-mediated regulation in distinct species.
An overproduction of GTP is observed in a mutant B. subtilis strain that lacks genes encoding functional RSH enzymes and is therefore unable to synthesize (p)ppGpp -known as a ppGpp 0 strain 3 . In media containing guanosine, which is incorporated into the bacterium via the salvage pathway, the GTP levels increase even further 3 . This imbalance in GTP metabolism leads to decreased survival during starvation 3 , and B. subtilis 83 , E. faecalis 4 and E. coli 25 ppGpp 0 strains are auxotrophic for specific amino acids. It has been suggested that auxotrophy in E. coli ppGpp 0 mutants is caused by insufficient transcription of amino acid biosynthesis genes 62 . In addition, the transcriptional repressor CodY has been suggested to contribute to the amino acid auxotrophy phenotype of a B. subtilis ppGpp 0 strain. CodY is a global metabolic regulator that inhibits transcription of target genes (which include several amino acid biosynthesis operons) when it is bound by branched amino acids and GTP 84 . Reducing the cellular concentration of GTP in the ppGpp 0 strain of B. subtilis (through mutations in the promoters or ORFs of guaB, guaA and gmk) leads to a substantial increase in survival and partially relieves the auxotrophy phenotype 85 , probably owing to amino acid production following partial de-repression of the CodY regulatory cascade. Surprisingly, a Pseudomonas putida ppGpp 0 strain is not auxotrophic for amino acids, highlighting the relevance of species-specific differences in (p)ppGpp-associated physiology 86 .
(p)ppGpp: TA systems and persistence Bacterial persisters arise stochastically in bacterial populations and are tolerant to multiple antibiotics, which has led to a growing interest in understanding their physiology, given the current global problems with antibiotic resistance 19, 87 . However, the molecular underpinnings of this phenotype have been poorly understood, and it has been suggested that several redundant mechanisms contribute to the phenomenon 88 . Slow growth is associated with recalcitrance to killing by antibiotics and other environmental insults, and so, by inference, slow growth was initially suggested to be crucial for the drug tolerance phenotype 89 . Considering that (p)ppGpp modulates bacterial growth rate 2 and metabolism 90 , this raised the possibility that the stringent response has a key role in persistence. However, until recently, direct evidence for this conjecture has been lacking, primarily because persisters are rare in growing populations and are therefore difficult to study.
A decade ago, an elegant study showed that an exponentially growing mutant of E. coli, in which hipA was mutated, generated persisters at a high rate. These cells grew slowly and survived treatment with ampicillin. Importantly, they also formed stochastically and independently of the drug 91 . A first hint of the underlying mechanism responsible for their emergence came from the realization that hipA encodes the toxin component of a toxin-antitoxin module (TA module), HipAB, and that the persistence phenotype of the hipA mutant was dependent on (p)ppGpp 92 . This rather enigmatic connection between (p)ppGpp, a TA module and persistence became clearer with the discovery that hipA encodes a kinase that phosphorylates and inhibits Glu-tRNA synthetase 93, 94 . Inhibition of this synthetase was found to lead to the accumulation of uncharged tRNA(Glu), which when loaded at the ribosomal A-site, resulted in the activation of RelA and increased (p)ppGpp levels 93, 95 . These findings provided a rationale for the observed dependency of hipA-mediated persistence on (p)ppGpp 92 and raised the possibility that HipA induces persistence by provoking an increase in (p)ppGpp levels. However, these observations did not exclude the alternative hypothesis that (p)ppGpp functions as the main regulator of persistence. This alternative model predicts that (p)ppGpp levels vary stochastically in single cells and that HipA activity is stimulated by (p)ppGpp in a positive feedback loop.
Indications of a more general involvement of TA modules in persistence came from the observation that the transcription of TA operons encoding mRNA endonucleases (mRNases) was higher in persisters than in wild-type, non-persister cells in the same population 96, 97 . TA-encoded mRNases are stable inhibitors of bacterial cell growth, whereas their corresponding antitoxins are metabolically unstable because they are readily degraded by Lon protease 98, 99 . Thus, the activity of Lon determines the levels of antitoxins and thereby regulates the activities of the toxins. Ectopic expression of TA-encoded toxins was shown to cause a marked increase in persistence, consistent with the idea that the toxins are inducers of persistence 93, 96, 97, 100 . Further strong support for this proposal came from the observation that progressive deletion of ten type II TA operons in E. coli led to a progressive reduction in persistence 100 . Together, these data suggested that TA modules encode cell growth inhibitors that are pivotal to bacterial persistence.
The link between (p)ppGpp, TA modules and persistence was illuminated by a study in which (p)ppGpp was found to be the master regulator of persistence and the mRNase toxins of TA modules were shown to encode persistence 'effectors' (REF. 101 ). This study showed that both (p)ppGpp levels and the transcription of TA operons vary stochastically in single cells. Furthermore, using an mCherry-RpoS (also known as RNAP σ-factor σ S ) fluorescent reporter protein as a reliable proxy of the (p)ppGpp level in single cells, this investigation found that persisters exhibited high levels of (p)ppGpp. The authors 101 proposed that the hierarchical signalling pathway involves an increase in (p)ppGpp levels, which is known to inhibit exopolyphosphatase activity 102 . As 
A-factor
A signalling molecule (2-isocapryloyl-3R-hydroxymethyl-γ-butyrolactone) that triggers secondary metabolism and morphogenesis in Streptomyces spp.
Fruiting bodies
Multicellular aggregates of myxobacteria that form as a result of nutrient deprivation.
a result, polyphosphate accumulates, and binds to and activates Lon protease 101, 103 . In turn, Lon degrades type II antitoxins, causing activation of the cognate toxins, ultimately inhibiting cell growth and inducing persistence 101 . It will be interesting to learn whether the inhibition of cell growth per se is sufficient to induce persistence or whether the TA-encoded toxins are required to induce transient drug tolerance.
The alarmone (p)ppGpp is present in the vast majority of bacterial species, including major pathogens 10 , thus raising two important questions: does (p)ppGpp also control persistence during infection, and if so, can this knowledge be exploited to devise improved treatment strategies? It is well known that, in almost all cases, (p)ppGpp is required for bacterial pathogens to be virulent, a fact that is consistent with the hostile and stressinducing environments that bacteria encounter during infection 16 . It is not yet known whether (p)ppGpp and the TA modules contribute to persistence during infection; however, two recent studies of Salmonella enterica subsp. enterica ser. Typhimurium persisters support this view. During infection, Salmonella spp. reside inside macro phages in a niche known as a Salmonella-containing vacuole, which is fairly acidic and nutrient poor. As a result, the stringent response is induced and stimulates the formation of persisters 104 . Moreover, S. Typhimurium mutants that have an impaired stringent response were found to produce fewer persisters in macrophages. Interestingly, persister formation in macrophages depended on both lon and TA-encoding genes; together with the findings for E. coli, this provides strong support for the notion that similar mechanisms lead to the emergence of both E. coli and Salmonella spp. persisters 104 . Another study found that moderately-to slow-growing S. Typhimurium shows increased survival following antibiotic treatment compared with fast-growing cells in host tissues 105 . The slow-growing cells had a higher level of (p)ppGpp-synthesizing enzymes, supporting the conjecture that (p)ppGpp controls persistence following antibiotic treatment in an infection context. Similarly, persistence of Pseudomonas aeruginosa, a gammaproteobacterium that is distantly related to E. coli and Salmonella spp., depends on (p)ppGpp during amino acid starvation, in biofilms and under oxidative stress 106, 107 . Future studies should investigate whether the involvement of (p)ppGpp in persistence is a widespread phenomenon and whether it could constitute the master regulator of persistence in more diverse bacterial pathogens 19, 101 .
Conclusions
In the four decades since the discovery of (p)ppGpp by Cashel and Gallant 20 , our understanding of the physiological roles of this alarmone has gradually evolved. Initially, the term stringent response was used to describe the RelA-mediated stress response to amino acid starvation, with a focus on the inhibition of rRNA transcription 108 . The concept of the stringent response has since been reformulated to refer to an integrated response to several different types of stress, including carbon and iron limitation, which are sensed by the other E. coli RSH enzyme, SpoT 5 . In recent years, there has been a greater appreciation of (p)ppGpp as a crucial component of normal physiology in unstressed conditions, with regulation of growth rate 2 , amino acid biosynthesis 4 and GTP metabolism 3 among the key roles of this versatile molecule.
Species-specific downstream effects of (p)ppGppmediated regulation are well recognized 109 . Prominent examples include alarmone involvement in virulence, such as the induction of cytotoxic phenol-soluble modulins (PSMs) following phagocytosis of Staphylococcus aureus 17 , as well as the regulation of antibiotic production in streptomycetes 110 , and of A-factor production and the development of fruiting bodies in M. xanthus 53 . Importantly, species-specific variations in the core molecular machinery of the stringent response are apparent: the cellular repertoire of RSHs differs greatly among different bacterial lineages 10 ; the regulation of transcription can be achieved via either direct binding of (p)ppGpp to RNAP 66, 67 or changes in the nucleotide pool 63 ; and finally, regulation of metabolic targets, such as GTP metabolism, varies widely among bacterial species 3, 81 . Thus, it has been proposed that the regulatory circuits of (p)ppGpp-mediated sensory systems are intimately linked to bacterial lifestyle 55 . A direct analysis of this conjecture requires a holistic characterization of all elements of the stringent response regulatory network, and great caution should be exercised when using biochemical data obtained for a model organism, such as E. coli, to rationalize the in vivo results obtained for any other species. A holistic understanding of the role of the stringent response in normal bacterial physiology is crucial for determining whether it might constitute a viable target for novel antibacterial agents
. Such inhibitors are also likely to be invaluable molecular tools for dissecting the mechanisms of the stringent response with biochemical, structural and microbiological approaches. As opposed to antibiotics, which generally target essential cellular processes, antivirulence compounds are expected to exert less selective pressure for resistance owing to the non-essentiality of the target 123 . Inhibition of the stringent response is a promising approach for disarming pathogens without killing them because bacterial strains that are incapable of guanosine tetraphosphate and guanosine pentaphosphate (collectively referred to as (p)ppGpp) production are viable, although they are metabolically compromised 83 . There have been several important advances in the development of molecular tools for inhibition of the stringent response pathway, demonstrating the potential of this pathway as a drug target. First, nucleotide-based inhibitors -the (p)ppGpp-based nucleotide Relacin and its derivatives -were developed to directly target the RelA-SpoT homologue (RSH) family of enzymes 124, 125 . Second, the antibiofilm peptide 1018 promotes the hydrolysis of (p)ppGpp that is formed in the cell 126 . However, our growing understanding of the importance of (p)ppGpp during normal physiology, such as its role in regulating amino acid biosynthesis 83 and growth rate 2 , suggests that inhibition of (p)ppGpp production would have a detrimental effect on bacterial survival and not only on virulence. Thus, in clinical settings, potential stringent-response inhibitors may not function strictly as antivirulence compounds but rather as antibiotics. Irrespective of the exact physiological consequences, selective inhibitors of the stringent response hold great promise as novel therapeutics.
